Celine Cano

Person

Newcastle-upon-Tyne, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Isoindolinone inhibitors of the MDM2-P53 interaction having antican...
- Patent number 12,071,429
- Issue date Aug 27, 2024
- Astex Therapeutics Limited
- Gianni Chessari
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isoindolinone inhibitors of the MDM2-P53 interaction having antican...
- Patent number 11,261,171
- Issue date Mar 1, 2022
- Astex Therapeutics Limited
- Gianni Chessari
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isoindolinone inhibitors of the MDM2-p53 interaction having antican...
- Patent number 10,981,898
- Issue date Apr 20, 2021
- Astex Therapeutics Limited
- Gianni Chessari
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isoindolinone inhibitors of the MDM2-p53 interaction having antican...
- Patent number 10,544,132
- Issue date Jan 28, 2020
- Astex Therapeutics Limited
- Gianni Chessari
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isoindolinone inhibitors of the MDM2-P53 interaction having antican...
- Patent number 10,526,311
- Issue date Jan 7, 2020
- Astex Therapeutics Limited
- Gianni Chessari
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrrolcarboxamide derivatives for the inhibition of ERK5
- Patent number 10,344,017
- Issue date Jul 9, 2019
- Tristan Reuillon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION HAVING ANTICAN...
- Publication number 20220106287
- Publication date Apr 7, 2022
- ASTEX THERAPEUTICS LIMITED
- Gianni CHESSARI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION HAVING ANTICAN...
- Publication number 20210276984
- Publication date Sep 9, 2021
- ASTEX THERAPEUTICS LIMITED
- Gianni CHESSARI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION HAVING ANTICAN...
- Publication number 20200079761
- Publication date Mar 12, 2020
- ASTEX THERAPEUTICS LIMITED
- Gianni CHESSARI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION HAVING ANTICAN...
- Publication number 20190055215
- Publication date Feb 21, 2019
- ASTEX THERAPEUTICS LIMITED
- Gianni CHESSARI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION HAVING ANTICAN...
- Publication number 20190016708
- Publication date Jan 17, 2019
- ASTEX THERAPEUTICS LIMITED
- Gianni CHESSARI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRROLCARBOXAMIDE DERIVATIVES FOR THE INHIBITION OF ERK5
- Publication number 20180170911
- Publication date Jun 21, 2018
- CANCER RESEARCH TECHNOLOGY LIMITED
- Tristan REUILLON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DNA-PK INHIBITORS
- Publication number 20110130386
- Publication date Jun 2, 2011
- Mark Frigerio
- C07 - ORGANIC CHEMISTRY

Celine Cano

Person

Patents Grantslast 30 patents

Isoindolinone inhibitors of the MDM2-P53 interaction having antican...

Isoindolinone inhibitors of the MDM2-P53 interaction having antican...

Isoindolinone inhibitors of the MDM2-p53 interaction having antican...

Isoindolinone inhibitors of the MDM2-p53 interaction having antican...

Isoindolinone inhibitors of the MDM2-P53 interaction having antican...

Pyrrolcarboxamide derivatives for the inhibition of ERK5

Patents Applicationslast 30 patents

ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION HAVING ANTICAN...

ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION HAVING ANTICAN...

ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION HAVING ANTICAN...

ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION HAVING ANTICAN...

ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION HAVING ANTICAN...

PYRROLCARBOXAMIDE DERIVATIVES FOR THE INHIBITION OF ERK5

DNA-PK INHIBITORS